biospecimen__admin__batch_number	287.61.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	CD86835C-6E2C-4DF0-B1FB-034C42E3EA91
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A4NI-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A4NI-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A4NI-01A
biospecimen__bio__biospecimen_barcode_bottom	0145631712
biospecimen__bio__day_of_creation	07
biospecimen__bio__day_of_shipment	25
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-DD-A4NI.7D4F801A-187C-4B20-96B3-98313D5252E3.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A27R
biospecimen__bio__plate_row	H
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2012
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A4NI
biospecimen__shared__patient_id	A4NI
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	3BBFB51C-98C8-4FFF-AF47-7B2B43B7702A
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.4
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	6
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__hist_hepato_carcinoma_risk	tobacco
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	9.5
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	13.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	12.4
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	67
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A4NI-F59476
clinical__clin_shared__bcr_followup_uuid	C8B81494-E953-4665-AC7A-A1E744B51ED8
clinical__clin_shared__cancer_first_degree_relative	6
clinical__clin_shared__day_of_form_completion	7
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	10
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	187
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	HBV Core Antibody
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	Yes
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	c7c139e0-f674-4002-a30b-da3ee7279efe
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A4NI-01A-11R-A27R-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	01cb2b46-cd4d-4cd1-b8b6-7fe48ba3fb05
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	5415a986-a165-4efa-8b71-e0e1aee68d7c
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	518aa9cc-71cf-4734-9d55-b435da99d300
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:37:39.749293-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	cab47aea-0419-5fdb-b522-1e18d521c17b
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1944
gdc__diagnoses__age_at_diagnosis	24516
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24516.0
gdc__diagnoses__days_to_last_follow_up	816.0
gdc__diagnoses__diagnosis_id	598cf464-1e6e-54a7-ab08-97f3f4fc4f72
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	33.464034613304484
gdc__exposures__exposure_id	07212f16-a2c6-5818-b958-56f00634e1dc
gdc__exposures__height	172.0
gdc__exposures__weight	99.0
gdc__file_id	55caeb6c-9123-4f97-a373-d66148d9fb25
gdc__file_name	0847bfd1-e96b-4246-9e9d-ee7e121e93d7.mirbase21.mirnas.quantification.txt
gdc__file_size	50214
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	afc2d98fd7fec9bb27cf36826be391c3
gdc__portions__is_ffpe	false
gdc__portions__portion_id	af623df2-dfd2-4817-adef-b1a6e74d4b50
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	357
gdc__samples__initial_weight	130.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	7D4F801A-187C-4B20-96B3-98313D5252E3
gdc__samples__sample_id	453e3da6-a1b3-4303-9a08-17d99027910f
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	10.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	5.0
gdc__slides__percent_tumor_cells	95.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	6f4822ff-b2be-4eb7-b518-72cddca89971
gdc__submitter_id	mirna_swap_dr11_242_MirnaExpression74b4b6e0-01ed-481c-a465-bb0d4cfc1f24_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	5817df91-7d5e-5162-854c-dacc8e1b4bbd
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:08.770+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/c7c139e0-f674-4002-a30b-da3ee7279efe-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/c7c139e0-f674-4002-a30b-da3ee7279efe-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129585
manually_curated__local_md5	3fcca1fff90e9cbb12b96f4079e736f2
manually_curated__opengdc_download_date	2018-10-16T17:12:46.000295+02:00
manually_curated__opengdc_file_md5	5853a95c2da33b3642182058422e2bc3
manually_curated__opengdc_file_size	50213
manually_curated__opengdc_id	c7c139e0-f674-4002-a30b-da3ee7279efe-meq
manually_curated__origin_file_size	129585
manually_curated__origin_last_modified_date	Tue Oct 16 17:15:00 CEST 2018
manually_curated__origin_md5	3fcca1fff90e9cbb12b96f4079e736f2
manually_curated__tissue_status	tumoral
